Our impact

The NIHR Birmingham Biomedical Research Centre has delivered substantial growth in research excellence, capacity and reach. Our multi-ethnic patient populations have enabled clinical research for patient benefit that reflects local and global diversity, maximising impact and value. We have delivered outstanding value for money as evidenced by the volume and quality of publications produced and by the return of £7 in leveraged income for every £1 NIHR have invested in the BRC.

Female researcher working in lab

We have published over 1,000 peer-reviewed articles.

Our impact: video series

Training opportunities and impact of the Birmingham BRC: a perspective from our Academy Members

Our Academic Career Development Lead, Dr Patricia Lalor, speaks to some of our Academy Members about

Training opportunities and impact of the Birmingham BRC: a perspective from our Academy Members
Building the next generation of Biomedical Researchers

Our Academic Career Development Lead, Dr Patricia Lalor, highlights the importance of training the next generation

Building the next generation of Biomedical Researchers
Collaborating with the public to shape our research and co-deliver impact

This video outlines the achievements of Public and Patient Involvement and Engagement (PPIE) in the NIHR

Collaborating with the public to shape our research and co-deliver impact
Innovating with Industry to drive transformation for patients and to support economic growth

Richard Fox (Strategic Business Engagement Partner – Life Sciences) and Professor Philip Newsome (Deputy Director of

Innovating with Industry to drive transformation for patients and to support economic growth
Delivering impactful research from the NIHR Birmingham Biomedical Research Centre

Professor Philip Newsome, Deputy Director of the NIHR Birmingham Biomedical Research Centre (BRC), reflects on some

Delivering impactful research from the NIHR Birmingham Biomedical Research Centre

Case studies

Woman measuring her blood pressure

AI-powered personalised medicine tool for hypertension being developed

Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.

Read more
Why are ATMPs important?

Why are ATMPs important?

Advanced Therapy Medicinal Products (ATMPs), which can be cell or gene therapies, show great potential in

Read more
Reducing liver transplant waiting lists

Reducing liver transplant waiting lists

The increased need for transplantation is widely recognised, as emphasised by National Health Service Blood and

Read more

Maximising patient reported outcomes in clinical trials

Patient-reported outcomes (PROs) are used in thousands of clinical trials worldwide to provide evidence of efficacy,

Read more
Endoscopic imaging for inflammatory bowel disease

Endoscopic imaging for inflammatory bowel disease

Gastrointestinal examination using an endoscope to look inside the body at abnormal tissue growth and inflammation

Read more
Ultrasound analysis detection of sarcopenia

Ultrasound analysis detection of sarcopenia

Despite its common occurrence and impact on patients, sarcopenia (a muscle wasting syndrome) is not routinely

Read more
Home-based intervention to reduce sarcopenia

Home-based intervention to reduce sarcopenia

It is already well established in age-related sarcopenia (a muscle wasting syndrome) that resistance exercise can

Read more
Load more
Two researchers discussing

We have secured over £70 million of research income.

Established research leadership

The NIHR Birmingham Biomedical Research Centre team have been at the international forefront of inflammation research for many years as demonstrated by our research outputs and our leadership of several national/regional centres.

There are currently more than 300 BRC-linked researchers pursuing over 850 research projects funded by the EU, Medical Research Council and Innovate UK, as well as charities including Cancer Research UK and the Wellcome Trust.